Product Information
ZOLPIDEM TART 3.5 MG TABLET SL is a generic product labeled by Endo USA Inc., priced at $5.7901 per EA under NDC 49884089911. Its NADAC has been published 377 times since Jul 17, 2019.
FDA first approved this application on Sep 11, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3.5 mg/1
Manufacturer
Endo USA Inc.NDC
49884089911
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
9/23/2026
Active Ingredients
ZOLPIDEM TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA204229FDA Approved
9/11/2017
TE Code
AB
On Market Since
9/11/2017
Pharmacological Classes
Price Statistics
The NADAC for ZOLPIDEM TART 3.5 MG TABLET SL has been published 377 times since Jul 17, 2019, and over the history we have for it it has risen 14.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.7901 per EA |
|---|---|
| All-time high | $6.7952 (Apr 13, 2022) |
| All-time low | $4.1960 (Jul 17, 2024) |
| 52-week high | $5.7951 |
| 52-week low | $5.3835 |
| Median price | $5.5110 |
| Average price | $5.6204 |
| Largest weekly change | +37.4% (Mar 20, 2024) |
| Weeks tracked | 377 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Zolpidem tartrate sublingual market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zolpidem tartrate sublingual market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
gamma-Aminobutyric Acid A Receptor Positive Modulator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZOLPIDEM TART 3.5 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for ZOLPIDEM TART 3.5 MG TABLET SL, manufactured by Endo USA Inc., is $5.7901 per EA (NDC 49884089911), effective Sep 30, 2026.
How has the price of ZOLPIDEM TART 3.5 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for ZOLPIDEM TART 3.5 MG TABLET SL has risen 14.9%. It has been tracked across 377 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for ZOLPIDEM TART 3.5 MG TABLET SL?
Since Jul 17, 2019, the NADAC for ZOLPIDEM TART 3.5 MG TABLET SL has ranged from a low of $4.1960 (Jul 17, 2024) to a high of $6.7952 (Apr 13, 2022), with a median of $5.5110 per EA.
Are there cheaper alternatives to ZOLPIDEM TART 3.5 MG TABLET SL?
No other NADAC-published product currently shares the active ingredient and strength of ZOLPIDEM TART 3.5 MG TABLET SL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZOLPIDEM TART 3.5 MG TABLET SL?
ZOLPIDEM TART 3.5 MG TABLET SL (NDC 49884089911) is labeled by Endo USA Inc., and CMS classifies it as a generic product.